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Poster Session II S265allogenic or autologous BMT at Sydney Children’s Hospital, Aus-
tralia between February 2002 and December 2004.
Results: 20% of the patients were at risk of malnutrition on ad-
mission. All patients received parenteral nutrition (PN) as their
standard nutritional therapy, which was commenced on a mean
of day + 1 and was infused for an average of 26 days. Our patients
received an average of 79%610.6(40-100%) of estimated energy
requirements from PN. The glucose/amino acid infusion was in-
adequate on 40% of PN days with the main reason due to fluid
overload causing a reduction in infusion rates. The lipid infusion
was inadequate on 60% of PN days mainly due to stoppages
when drugs and/or blood products were infused. The mean per-
centage weight change on discharge was +0.36 4.7%. This had
a large range of between –9.9% to + 7.9% of body weight and
did not appear to relate to adequacy of parenteral nutrition during
transplant. We found that those patients who had weight loss on
discharge had greater number of days off PN prior to discharge
than those with no weight loss. Those patients who received
enteral nutrition (21%) prior to discharge had no weight loss on
discharge.
Conclusion: This study showed that although frequent rate reduc-
tions in nutrition infusions did occur due to fluid overload or drug
incompatibility with PN, patients still received the majority of their
nutritional requirements. Weight loss on discharge from transplant
may be more indicative of the adequacy of oral/enteral nutrition
prior to discharge rather than the adequacy of the nutrition support
during the transplant. Long-term consequences of inadequate nutri-
tion during a BMT as well as nutritional issues post BMT requires
further study.
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H1N1 INFECTION IN STEM CELL TRANSPLANT PATIENTS
Gupta, S.1, Bayer, R.-L.2 1Nalitt Institute of Cancer and Blood Related
Disorders, Staten Island University Hospital, NY; 2Monter Cancer Cen-
ter, North Shore-Long Island Jewish Health System, NY
Influenza A virus can be a significant cause of morbidity and mor-
tality in the general population as well as in immunocompromised
patients.
We present instances where stem cell transplant patients devel-
oped H1N1 infection with encouraging outcomes.
Case 1: A 26 year old male with history of relapsed Hodgkin’s dis-
ease status post autologous peripheral blood stem cell transplant in
December 2008, presented with fever and cough six months after
transplantation. His chest X-ray revealed consolidation and CT
scan of the chest showed ground glass opacities throughout the
lungs. The patient was started on intravenous antibiotics and a respi-
ratory panel was sent. The panel was positive for non-typeable influ-
enza A, indicative of H1N1 infection. The antibiotics were stopped
and Oseltamavir was initiated. After 5 days of treatment, the patient’s
symptoms resolved, and his repeat CT scan showed marked resolu-
tion of the ground glass opacities.
Case 2: A 64 year old male patient with history of relapsed, trans-
formed low grade lymphoma, status post unrelated reduced intensity
allogeneic bone marrow transplantation in December 2008, compli-
cated by GVHD, presented in May 2009, with new onset throat dis-
comfort, cough and fever. A respiratory panel was positive for non-
typeable influenza A and CT scan of the chest revealed bilateral
lung consolidation. The patient was started on Oseltamavir, with
complete resolution of symptoms and improved CT findings.
Discussion: In March 2009, the pandemic caused by H1N1 influ-
enza claimed thousands of lives. This strain of virus represents a qua-
druple reassortment of two swine strains, one human strain and one
avian strain.
Although real time PCR is the most sensitive and specific test for
the diagnosis of H1N1, recent CDC guidelines, do not recommend
this test for every presumed case of H1N1 infection. During the
spring of 2009, a diagnosis of H1N1 infection could be made, if a pa-
tient presented with signs and symptoms of upper or lower respira-
tory tract involvement and if influenza A was identified on
a respiratory panel. Our patients were diagnosed with H1N1 infec-
tion and with the use of Oseltamavir, had complete response and res-
olution of symptoms with minimal morbidity.
Thus we conclude that H1N1 infection may not be associated with
significant morbidity and mortality in stem cell transplant patients if
a timely diagnosis is made and treatment is initiated.290
RED CELL CONTENT IN PERIPHERAL HEMATOPOIETIC PROGENITOR
CELL (HPCA) COLLECTIONS FOR TRANSPLANT IN PEDIATRIC PATIENTS.
COMPARISON TO ADULT MATCHED UNRELATED (URD) PERIPHERAL
BLOOD COLLECTIONS. TO DETERMINE THE MAXIMUM ACCEPTABLE
VOLUME OF RED CELLS FOR INFUSION
Villa, M.1, Schneiderman, J.2, Duerst, R.2, Shook, T.1, Collins, J.3,
Meagher, R.1, Kletzel, M.2 1Northwestern Memorial Hospital, Chicago,
IL; 2Northwestern University Feinberg School of Medicine, Chicago, IL;
3Children’s Memorial Hospital, Chicago, IL
We assessed the amount of red cells in peripheral blood collec-
tions from pediatric patients and compare them to adult URD col-
lections.
Twelve pediatric HPCA collections (5 allo and 7 auto) using the
BCT Spectra at Children’s Memorial Hospital were compared to
18 URD collections from multiple institutions received at North-
western Memorial Hospital Cellular Processing Facility (CTPF)
from January to July 2009. Column statistics and t test were per-
formed on Prism software.
The median total product volume collected per harvest of the
URD was 293 ml (range 166-447) mean 299 SEM + 18 (95% CI
261-337) The median total product volume collected from pediatric
donors was 133 (range 16-299) mean 138 SEM + 29 (95% CI 75-202)
p\0.0001. The median Hct per collection of the URD was 6.5%
(range 3-17) mean 7.6 SEM +0.8 (95% CI 5.8-9.3) and from the pe-
diatric collections, the median Hct was 9.5% (range 4.0-19) mean 9.6
SEM + 1.4 (95% CI 6.3-2.7) p5 0.99. The median red cell volume
per collection for the URDs was 24 ml (range 9-46) mean 23
SEM + 2.3 (95% CI 18-28) while for the pediatric donors, the me-
dian was 8.5 ml (range 4-36) mean 12 SEM +2.4 (95% CI 6.1-
17.0) p5 0.003.
The Hct in URD vs. pediatric collections was not statistically sig-
nificantly different. Since the red cell content is dependent on the to-
tal product volume, the red cell volume was greater in the URD
collections. HPCA infusions.CRA – DATA MANAGEMENT
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CLINICAL IMPACT OF STOMATITIS SEVERE IN PATIENTS RECEIVING
MYELOBLATIVE, NON MYELOABLATIVE AND REDUCED INTENSITY CON-
DITIONING REGIMENS AND HAEMATOPOIETIC PROGENITOR TRANS-
PLANTATION: EXPERIENCE OF SINGLE CENTER
Gomez-Morales, E.1, Azucena, S.-G.2 1ABC Medical Center, Mexico;
2ABC Medical Center, Mexico
Introduction: Stomatitis severe is the mayor limiting dose by pre-
parative regimen in stem cell transplantation reporting percentages
that vary widely (0% to 100%) associated with intensity chemother-
apy but these percentages not are real (0% with minimal intensity
and 100% with myeloablative regimen) and this represent the goal
of this study additional to analyze their clinical impact on another
complications in transplantation field.
Patients and Methods: Observational and transversal study was
made in patients receiving stem cell transplantation since November
2002 to September 2009 in ABC Medical Center Mexico City. All
were older 1 year (female or male). The preparative regimen were
separated into myeloablative, non myeloablative (or moderate-inten-
sity) and minimal-intensity in relation with CIBMTR criteria. The
presence of erytema, edema, pain, sore throat and ulcerations mouth
after chemotherapy was defined stomatitis and their severity was
graduated with NCTC v3.0 scale (Stomatitis grade 3 y 4 was defined
severe).
Results: 52 patients with medium age 29 years old (range 2-72).
Predominance male (56.6%; ratio M:F 1.4:1). 21 patients received
myeloablative regimen (40.5%), 19 non myeloablative (36.5%) y
12 minimal-intensity (23%). 23 patients presented stomatitis se-
vere (44.23%) predominance in myeloablative regimens (56.52%
vs 30.4% non myeloablative y 13% minimal intensity) and alloge-
neic transplantation (60.86%). 65.2% of cases with stomatitis
grade 3 required opiates infusion and 100% total parenteral nu-
trition (independently preparative regimen). The febrile
